IP Verse

Crispr-Based Genome Modification And Regulation - EP3360964B1

PatentPatent Analysis

EP3360964

SIGMA ALDRICH
Application Number
EP18156734A
Filing Date
Dec 5, 2013
Status
Revoked
Nov 22, 2024
Grant Date
Oct 2, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3363902B1
EP2928496B1
EP3138911B1

Bibliography

The patent EP3360964B1 was granted to Sigma Aldrich on Oct 2, 2019 following the initial filing on Dec 5, 2013 under the application number EP18156734A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREJul 2, 2020ADMISSIBLE
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJul 2, 2020ADMISSIBLE
SCHLICHJul 2, 2020ADMISSIBLE
BASFJul 1, 2020ADMISSIBLE
PATENT BOUTIQUEMar 2, 2020ADMISSIBLE
GRUNDFeb 4, 2020ADMISSIBLE
BAYER BAYERDec 23, 2019ADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBNov 22, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents